Endymed (Israel) Today

ENDY Stock   337.00  7.00  2.12%   

Performance

3 of 100

 
Low
 
High
Insignificant

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Endymed is trading at 337.00 as of the 29th of March 2024, a 2.12% increase since the beginning of the trading day. The stock's open price was 330.0. Endymed has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Endymed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.. The company has 13.76 M outstanding shares. More on Endymed
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Endymed Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Endymed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Endymed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, Endymed Medical Ltd.Yoram Hert
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Endymed (ENDY) is traded on Tel Aviv Stock Exchange in Israel and employs 41 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Endymed's market, we take the total number of its shares issued and multiply it by Endymed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Endymed operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 13.76 M outstanding shares. Endymed has accumulated about 5.02 M in cash with 4.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39.
Check Endymed Probability Of Bankruptcy
Ownership Allocation
Endymed retains a total of 13.76 Million outstanding shares. Endymed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Endymed Ownership Details

Endymed Stock Price Odds Analysis

What are Endymed's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Endymed jumping above the current price in 90 days from now is about 5.66%. The Endymed probability density function shows the probability of Endymed stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Endymed has a beta of 0.541 suggesting as returns on the market go up, Endymed average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Endymed will be expected to be much smaller as well. Additionally, endymed has an alpha of 0.0016, implying that it can generate a 0.001603 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 337.0HorizonTargetOdds Above 337.0
94.24%90 days
 337.00 
5.66%
Based on a normal probability distribution, the odds of Endymed to move above the current price in 90 days from now is about 5.66 (This Endymed probability density function shows the probability of Endymed Stock to fall within a particular range of prices over 90 days) .

Endymed Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Endymed market risk premium is the additional return an investor will receive from holding Endymed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Endymed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Endymed's alpha and beta are two of the key measurements used to evaluate Endymed's performance over the market, the standard measures of volatility play an important role as well.

Endymed Stock Against Markets

Picking the right benchmark for Endymed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Endymed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Endymed is critical whether you are bullish or bearish towards Endymed at a given time. Please also check how Endymed's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Endymed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Endymed Corporate Directors

Endymed corporate directors refer to members of an Endymed board of directors. The board of directors generally takes responsibility for the Endymed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Endymed's board members must vote for the resolution. The Endymed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Amiram GoldmanExternal DirectorProfile
Eran NaorExternal Director, Independent DirectorProfile
Ronen ZadokExternal DirectorProfile
Yoram HarthFounder, Director & Chief Medical OfficerProfile

How to buy Endymed Stock?

Before investing in Endymed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Endymed. To buy Endymed stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Endymed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Endymed stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Endymed stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Endymed stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Endymed, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Endymed?

The danger of trading Endymed is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Endymed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Endymed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Endymed is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Endymed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Endymed Stock analysis

When running Endymed's price analysis, check to measure Endymed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endymed is operating at the current time. Most of Endymed's value examination focuses on studying past and present price action to predict the probability of Endymed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endymed's price. Additionally, you may evaluate how the addition of Endymed to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Please note, there is a significant difference between Endymed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Endymed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Endymed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.